Elicio Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Boston, MA
ELTX chart
What traders are saying about $ELTX
Latest postsElicio Therapeutics, Inc. news
- Elicio Therapeutics, Inc. : H.c. Wainwright C
Moomoo ·
- HC Wainwright & Co. maintains Elicio Therapeutics at Buy, lowers price target to $21 from $23
TradingView ·
- Weekly Recap: AMPLIFY-7P misses endpoint and cash runway reaches 2027
TradingView ·
- Elicio Therapeutics, Inc. (ELTX) options chain – Yahoo Finance
Yahoo Finance Singapore ·
- Can Elicio Therapeutics (NASDAQ:ELTX) Afford To Invest In Growth?
Simply Wall St ·
- Elicio Therapeutics Inc (9HA.DU) Seasonal returns chart
Yahoo Finance UK ·
- Elicio Therapeutics Inc (9HA.DU) Seasonal returns chart - Yahoo Finance
Yahoo Finance Singapore ·
- With $30.9M in cash, Elicio Therapeutics (ELTX) still flags going-concern doubt.
Stock Titan ·
- Elicio Therapeutics: Q3 Earnings Snapshot
Yahoo Finance ·
- Elicio Therapeutics Reports Q3 2026 Net Loss of $8.0 Million and Cash of $30.9 Million
TradingView ·
- Elicio Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
Yahoo Finance ·
- Elicio Therapeutics to Host Virtual KOL Event on November 11, 2026: ELI-002 7P for Metastatic and Neoadjuvant PDAC
Yahoo Finance ·
Elicio Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | $2.3M |
| Net income | -$39.6M | -$51.9M | -$35.2M | -$28.2M |
| Diluted EPS | $-2.58 | $-4.25 | $-6.96 | $-89.27 |
| Total assets (year end) | $25.9M | $28.2M | $27.1M | $22.7M |
| Cash and equivalents (year end) | $18.6M | $17.6M | $12.9M | $6.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Elicio Therapeutics, Inc.
- Ticker
- ELTX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Boston, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1601485
- Former names
- Angion Biomedica Corp.
Frequently asked questions
What exchange is Elicio Therapeutics, Inc. listed on?
Elicio Therapeutics, Inc. trades on the Nasdaq under the ticker symbol ELTX.
What industry is Elicio Therapeutics, Inc. in?
Elicio Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Elicio Therapeutics, Inc. headquartered?
Elicio Therapeutics, Inc.'s business address on file with the SEC is in Boston, MA.
When does Elicio Therapeutics, Inc.'s fiscal year end?
Elicio Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Elicio Therapeutics, Inc. report?
Elicio Therapeutics, Inc. reported $2.3M in revenue for calendar year 2022, according to its SEC filings.